Thomas Hubka - Histogen Director Sec
HSTODelisted Stock | USD 0.03 0.00 0.00% |
Insider
Thomas Hubka is Director Sec of Histogen
Age | 36 |
Phone | 858 526 3100 |
Web | https://www.histogen.com |
Histogen Management Efficiency
The company has return on total asset (ROA) of (0.5381) % which means that it has lost $0.5381 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1989) %, meaning that it created substantial loss on money invested by shareholders. Histogen's management efficiency ratios could be used to measure how well Histogen manages its routine affairs as well as how well it operates its assets and liabilities.Histogen currently holds 4.63 M in liabilities with Debt to Equity (D/E) ratio of 0.31, which is about average as compared to similar companies. Histogen has a current ratio of 12.96, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Histogen's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
John Cini | Sonnet Biotherapeutics Holdings | 72 | |
Manuel Dafonseca | Sonnet Biotherapeutics Holdings | N/A | |
MD FAAAAI | Palisade Bio | N/A | |
Gregory MBA | Artelo Biosciences | 62 | |
Susan Dexter | Sonnet Biotherapeutics Holdings | 70 | |
Elif McDonald | Curis Inc | N/A | |
Deborah Knobelman | Senti Biosciences | 50 | |
Jan MSc | Bright Minds Biosciences | 60 | |
Emer MBA | Bright Minds Biosciences | 58 | |
Justin Trojanowski | Tempest Therapeutics | 36 | |
Daniel MD | Tonix Pharmaceuticals Holding | N/A | |
Hillel MBA | Entera Bio | 47 | |
MD FACP | Sonnet Biotherapeutics Holdings | 67 | |
Tomasz George | Virax Biolabs Group | 40 | |
Cameron Shaw | Virax Biolabs Group | 37 | |
Miranda MBA | Entera Bio | 48 | |
Anne Moon | Tempest Therapeutics | N/A | |
CPA CPA | Tonix Pharmaceuticals Holding | 50 | |
Philip Lee | Senti Biosciences | 42 | |
Seth MD | Tonix Pharmaceuticals Holding | 67 | |
Jason Davis | Virax Biolabs Group | 53 |
Management Performance
Return On Equity | -1.2 | |||
Return On Asset | -0.54 |
Histogen Leadership Team
Elected by the shareholders, the Histogen's board of directors comprises two types of representatives: Histogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Histogen. The board's role is to monitor Histogen's management team and ensure that shareholders' interests are well served. Histogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Histogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Stephen Hill, VP Controller | ||
Steven Mento, Interim Chairman | ||
Thomas Hubka, Director Sec | ||
Gail Naughton, Founder Advisor | ||
Susan Knudson, CEO, President |
Histogen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Histogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.2 | |||
Return On Asset | -0.54 | |||
Operating Margin | (705.00) % | |||
Current Valuation | (4.46 M) | |||
Shares Outstanding | 4.27 M | |||
Shares Owned By Insiders | 2.85 % | |||
Number Of Shares Shorted | 67.03 K | |||
Price To Book | 0.02 X | |||
Price To Sales | 4.50 X | |||
Revenue | 19 K |
Pair Trading with Histogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Histogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will appreciate offsetting losses from the drop in the long position's value.Moving against Histogen Stock
The ability to find closely correlated positions to Histogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Histogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Histogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Histogen to buy it.
The correlation of Histogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Histogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Histogen Stock
If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |